Oncobiologics names Canute to board of directors
Wednesday, October 12, 2011
Oncobiologics has named Scott Canute to its board of directors.
Over the course of his 30-year career, Canute played a vital role in leading Eli Lilly’s global manufacturing operations. Most recently, he spent more than a year as president of global manufacturing and corporate operations for Genzyme.
“Scott Canute has been a distinguished leader at major biopharmaceutical organizations throughout his career,” said Oncobiologics founder & CEO Pankaj Mohan, Ph.D. “I have known and admired Scott as my mentor for many years, and I am honored that he will share his experience and strategic insight to our efforts at Oncobiologics. We look forward to guidance from Scott as a member of our board.”